We are live on ! Find out more

Doximity

DOCS

Market cap $4.7B

26.35 USD

-0.75

2.77%

At close Updated Sep 4, 4:00 PM EDT

Pre-market

After hours

26.43

+0.08

0.3%

1 day

-2.77%

5 days

1.97%

1 month

20.37%

3 months

27.29%

6 months

-0.34%

Year to date

-39.13%

1 year

-61.54%

5 years

-73.18%

10 years

-50.28%

About: Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.

Employees: 880

Healthcare Health Information Services

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 27.7%

Neutral 59.6%

Negative 12.8%

Overworked Doctors Bet on AI to Boost Their Pay

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced new data indicating that physicians are finding an unexpected source of optimism in AI. Rather than viewing the technology as a threat, nearly a quarter expect it to increase their total compensation within the next year, and two-thirds believe staying current with AI will give them a meaningful earnings edge over peers who don't. The findings are part of Dox.

Overworked Doctors Bet on AI to Boost Their Pay

Zacks Investment Research

Reasons to Retain Doximity Stock in Your Portfolio for Now

DOCS' AI expansion is opening new growth avenues, but rising AI costs and tight pharma budgets could temper near-term gains.

Reasons to Retain Doximity Stock in Your Portfolio for Now

The Motley Fool

A Doximity Director Moved 7,500 Shares the Day the Stock Popped 33%. Here's What to Know

Cabral sold 7,500 shares for an estimated $293,000 on August 7. The disposition involved the exercise of stock options followed by an immediate open-market sale.

A Doximity Director Moved 7,500 Shares the Day the Stock Popped 33%. Here's What to Know

The Motley Fool

What Investors Should Know of This Doximity Officer's Latest Insider Transaction

The transaction involved the exercise of options and a subsequent disposition valued at $140,400 at $24.84 per share. The activity was split between a Rule 10b5-1 trading plan sale to cover tax obligations and mandated shares withheld by the issuer for restricted stock unit vesting.

What Investors Should Know of This Doximity Officer's Latest Insider Transaction

The Motley Fool

Doximity Handed Its President 150,000 Options Last Month. Here's What the Latest Filing Signals for Investors

The shares traded represent about $111,154 in total value based on the execution price on August 15. This disposition reduced the insider's direct equity holdings by 8%.

Doximity Handed Its President 150,000 Options Last Month. Here's What the Latest Filing Signals for Investors

The Motley Fool

Doximity's New CFO Just Filed His First Form 4. Here's What Long-Term Investors Should Know.

The disposition involved 15,311 shares valued at about $380,000 based on a weighted average price of $24.80 per share. The transaction reduced the insider's direct holdings by 3% following the underlying vesting event.

Doximity's New CFO Just Filed His First Form 4. Here's What Long-Term Investors Should Know.

The Motley Fool

Doximity's Co-Founder Just Filed a Form 4. Is There Anything in It Worth Worrying About?

The CEO disposed of 8,505 shares for approximately $211,000 based on the transaction-date pricing. This transaction represented just 0.3% of the executive's direct equity holdings.

Doximity's Co-Founder Just Filed a Form 4. Is There Anything in It Worth Worrying About?

The Motley Fool

Atlassian and Doximity Just Surged 30% After Earnings: 3 Software Stocks with the Same Setup

Recent commentary in the DevSecOps sector has been positive, which could help fuel GitLab's revenue. UiPath is a highly shorted stock that could defy expectations.

Atlassian and Doximity Just Surged 30% After Earnings: 3 Software Stocks with the Same Setup

The Motley Fool

Why Doximity Stock Skyrocketed on Friday

Doximity's AI assistant is earning favorable reviews from independent researchers. Customer usage of Doximity's AI services is soaring.

Why Doximity Stock Skyrocketed on Friday

Doximity: I Called The Pop Over A Month Ago, But Now Is The Time To Wait (Rating Downgrade)

Doximity delivered strong fiscal Q1 2027 results, validating my prior bullish stance on valuation and AI-driven growth. The stock surged over 30% intraday, reflecting the market's recognition of DOCS's evolving business model and earnings strength. DOCS is transforming physician searches into a new commercial marketplace, leveraging AI Search to monetize real-time physician intent.

Doximity: I Called The Pop Over A Month Ago, But Now Is The Time To Wait (Rating Downgrade)

See News Rankings

Price charts implemented using Lightweight Charts™